FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma

There is an urgent need to develop new and more effective therapeutic strategies and agents to treat hepatocellular carcinoma (HCC). We have recently found that deletion of Fak in hepatocytes before tumors form inhibits tumor development and prolongs survival of animals in a c-MET (MET)/β-catenin (C...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gene Expr
Egile Nagusiak: Shang, Na, Arteaga, Maribel, Zaidi, Ali, Cotler, Scott J., Breslin, Peter, Ding, Xianzhong, Kuo, Paul, Nishimura, Michael, Zhang, Jiwang, Qiu, Wei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cognizant Communication Corporation 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5064945/
https://ncbi.nlm.nih.gov/pubmed/27142958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/105221616X691604
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak